These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2874535)

  • 1. Is tofisopam an atypical anxiolytic?
    Pellow S; File SE
    Neurosci Biobehav Rev; 1986; 10(2):221-7. PubMed ID: 2874535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacologic effects of tofizopam (Grandaxin)].
    Petócz L
    Acta Pharm Hung; 1993 Mar; 63(2):79-82. PubMed ID: 8100112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indirect dopaminergic effects of tofisopam, a 2,3-benzodiazepine, and their inhibition by lithium.
    Chopin P; Stenger A; Couzinier JP; Briley M
    J Pharm Pharmacol; 1985 Dec; 37(12):917-9. PubMed ID: 2868105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of cross-tolerance in mice between the stimulatory and depressant actions of novel anxiolytics in the holeboard.
    Pellow S; File SE
    Behav Brain Res; 1987 Feb; 23(2):159-66. PubMed ID: 2882763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype.
    McKernan RM; Rosahl TW; Reynolds DS; Sur C; Wafford KA; Atack JR; Farrar S; Myers J; Cook G; Ferris P; Garrett L; Bristow L; Marshall G; Macaulay A; Brown N; Howell O; Moore KW; Carling RW; Street LJ; Castro JL; Ragan CI; Dawson GR; Whiting PJ
    Nat Neurosci; 2000 Jun; 3(6):587-92. PubMed ID: 10816315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticonvulsant, anxiolytic, and non-sedating actions of imidazenil and other imidazo-benzodiazepine carboxamide derivatives.
    Auta J; Kadriu B; Giusti P; Costa E; Guidotti A
    Pharmacol Biochem Behav; 2010 Jun; 95(4):383-9. PubMed ID: 20227434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropharmacology of a new psychotropic 2,3-benzodiazepine.
    Andrási F; Horváth K; Sineger E; Berzsenyi P; Borsy J; Kenessey A; Tarr M; Láng T; Kórösi J; Hámori T
    Arzneimittelforschung; 1987 Oct; 37(10):1119-24. PubMed ID: 2893623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new sensitive method which unlike the Vogel test detects the anxiolytic effect of tofisopam.
    Miklya I; Knoll J
    Pol J Pharmacol Pharm; 1988; 40(6):561-72. PubMed ID: 2908362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GABA and the behavioral effects of anxiolytic drugs.
    Sanger DJ
    Life Sci; 1985 Apr; 36(16):1503-13. PubMed ID: 2858804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of GABAA receptor subtypes to the anxiolytic-like, motor, and discriminative stimulus effects of benzodiazepines: studies with the functionally selective ligand SL651498 [6-fluoro-9-methyl-2-phenyl-4-(pyrrolidin-1-yl-carbonyl)-2,9-dihydro-1H-pyridol[3,4-b]indol-1-one].
    Licata SC; Platt DM; Cook JM; Sarma PV; Griebel G; Rowlett JK
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1118-25. PubMed ID: 15687371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat.
    Pellow S; File SE
    Pharmacol Biochem Behav; 1986 Mar; 24(3):525-9. PubMed ID: 2871560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical pharmacology of buspirone hydrochloride.
    Skolnick P; Paul SM; Weissman BA
    Pharmacotherapy; 1984; 4(6):308-14. PubMed ID: 6151169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buspirone: review of its pharmacology and current perspectives on its mechanism of action.
    Eison AS; Temple DL
    Am J Med; 1986 Mar; 80(3B):1-9. PubMed ID: 2870639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [(3)H]-girisopam, a novel selective benzodiazepine for the 2, 3-benzodiazepine binding site.
    Horváth EJ; Salamon C; Bakonyi A; Fekete MI; Palkovits M
    Brain Res Brain Res Protoc; 1999 Jul; 4(2):230-5. PubMed ID: 10446419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (omega) receptor subtypes.
    Griebel G; Perrault G; Letang V; Granger P; Avenet P; Schoemaker H; Sanger DJ
    Psychopharmacology (Berl); 1999 Sep; 146(2):205-13. PubMed ID: 10525757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.
    Depoortere H; Zivkovic B; Lloyd KG; Sanger DJ; Perrault G; Langer SZ; Bartholini G
    J Pharmacol Exp Ther; 1986 May; 237(2):649-58. PubMed ID: 2871178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticonvulsant and anxiolytic-like effects of compounds isolated from Polygala sabulosa (Polygalaceae) in rodents: in vitro and in vivo interactions with benzodiazepine binding sites.
    Duarte FS; Marder M; Hoeller AA; Duzzioni M; Mendes BG; Pizzolatti MG; De Lima TC
    Psychopharmacology (Berl); 2008 Apr; 197(3):351-60. PubMed ID: 18157522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can drug effects on anxiety and convulsions be separated?
    Pellow S
    Neurosci Biobehav Rev; 1985; 9(1):55-73. PubMed ID: 2858082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates.
    Rowlett JK; Platt DM; Lelas S; Atack JR; Dawson GR
    Proc Natl Acad Sci U S A; 2005 Jan; 102(3):915-20. PubMed ID: 15644443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of the novel anxiolytic beta-carboline abecarnil in rodents and primates.
    Ozawa M; Nakada Y; Sugimachi K; Yabuuchi F; Akai T; Mizuta E; Kuno S; Yamaguchi M
    Jpn J Pharmacol; 1994 Mar; 64(3):179-87. PubMed ID: 7912751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.